JPMorgan keeps an Overweight rating on UnitedHealth (UNH) after the company disclosed it is complying with formal criminal and civil requests from the Department of Justice. The company has also launched an internal review of its related risk-coding practices, the analyst tells investors in a research note. JPMorgan thinks any litigation resulting from the DOJ’s requests could be lengthy and shaped by the outcome of existing litigation and the court-appointed Special Master’s report regarding the company’s Medicare Advantage practices. As such, the firm finds it challenging to handicap any real impact to UnitedHealth. The stock in morning trading is down 2% to $287.17.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Morning Movers: Dow Inc. falls following Q2 report and dividend cut
- UnitedHealth Cooperates with DOJ on Medicare Inquiry
- UnitedHealth down 4% after disclosing criminal and civil requests from DOJ
- UnitedHealth complying with formal criminal and civil requests from DOJ
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!